National and Kapodistrian University of Athens
Μελέτη της προθυμοσίνης α με τη χρήση ειδικών ραδιοεπισημασμένων παραγώγων του μορίου σε in vitro και in vivo τεχνικές
Abstract
dc:descriptionProthymosin alpha (ProTα) is a conserved mammalian polypeptide (human sequence 109amino acid-long) exerting a pleiotropic immunoenhancing activity. The N-terminal fragment[1-28] of the molecule, which is identical with the immunostimulating peptide thymosin α1(Tα1), was earlier considered as the immunoactive region of the polypeptide; however,recent data suggest that ProTα may exert a discrete immunomodulating action through itsC-terminal decapeptide [100-109] or its central region [51-89], via targeting Toll-likereceptor- 4 (TLR4). In the frame of this work, a derivative of the C-terminal fragmentProTα[100-109] (ProTα-D1) that can be radiolabeled with 99mTc was developed. Thebiological activity of the non-radioactive 185/187rhenium-complex of this derivative([Re]ProTα-D1, structurally similar with [99mTc]ProTα-D1) was evaluated in suitable in vitrobioassays and in assays correlated with TLR4 surface expression using humanneutrophils, in comparison with intact ProTα, various synthetic ProTα fragments/derivatives and negative control peptides. Subsequent cell-binding studies revealed specific, time-dependent and saturable binding of [99mTc]ProTα-D1 on neutrophils, which was inhibited by intact ProTα and the synthetic ProTα[100-109], as well as by a “prototype” TLR4-ligand (lipopolysaccharide from Escherichia coli, LPS), but not by synthetic Τα1, the central ProTα region and negative control peptides. Our results support the existence of ProTα-binding sites on human neutrophils, recognizing the C-terminal region [100-109], which might involve TLR4. Due to the properties of the radioisotope used for the labeling, [99mTc]ProTα-D1 was further evaluated in in vivo biodistribution and whole body imaging studies in mice bearing an inflammation model. These studies provided important information related to the pharmacokinetic profile of [99mTc]ProTα-D1 but above all revealed the capacity of [99mTc]ProTα-D1 to selectively target inflammatory loci in vivo.The accumulation of [99mTc]ProTα-D1 in inflammatory sites is specific and due to thepresence of the C-terminal decapeptide ProTα[100-109]. Overall, the present thesissignificantly contributed to the enrichment of our basic knowledge on the extracellularmode of action of ProTα, both in vitro and in vivo. Additionally, such data will facilitatefuture exploitation of the polypeptide or a smaller active fragment thereof, such as ProTα[100-109], in the clinical setting.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2015
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Karachaliou, Chrysoula-Evangelia
- Καραχάλιου, Χρυσούλα-Ευαγγελία
Subjects
dc:subject × 16- Προθυμοσίνη α (ΠροΤα)
- Επισήμανση πεπτιδίων με 99m Tc
- Ανθρώπινα ουδετερόφιλα
- In vitro μελέτες κυτταρικής δέσμευσης
- In vivo μελέτες βιοκατανομής και απεικόνισης
- Prothymosin α (PrοΤα)
- 99mTc radiolabeling
- Human neutrophils
- In vitro cell binding studies
- In vivo biodistribution and imaging studies
- Φυσικές Επιστήμες
- Χημεία
- Βιολογία
- Natural Sciences
- Chemical Sciences
- Biological Sciences
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/44026